Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend

Bulletin Express

Apr 14

Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.

The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1108089810"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108089810\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108089810?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108089810","market":"us","top_or_hot":-1,"title":"Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend","media":"Bulletin Express","content":"<p>Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.</p>\n<p>The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-14 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.</p>\n<p>The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01858","symbol_name":"春立医疗","start_time":0,"source_url":"","article_id":"1108089810","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108089810","pubTimestamp":1776157413,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01858":"春立医疗"},"translate_title":"春立医疗定于2026年4月29日召开董事会批准第一季度业绩并讨论中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01858":1},"content_text":"Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.\nThe notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}